KRAS and lung carcinoma: A target sequencing analysis did not detect any possible somatic driver mutations commonly observed in lung cancer [18], such as EGFR, HER2, KRAS, ALK, MET, or PIK3CA, suggesting that primary pulmonary malignant melanomas may have different oncogenic pathways from primary lung cancer from the viewpoint of driver oncogenes.